The immunophenotype of peripheral blood lymphocytes in clinically healthy dogs and dogs with lymphoma in remission

Journal of Veterinary Internal Medicine

Volumn 19, Issue 2, 2005, Pages 193-199

  Gauthier, M J ^a   Aubert, I ^a   Abrams Ogg, A ^a   Woods, J P ^a   Bienzle, D ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Canine; Chemotherapy; Flow cytometry; Lymphoproliferative disease

Indexed keywords

ALPHA4 INTEGRIN; ANTIINFECTIVE AGENT; CD3 ANTIGEN; CD45 ANTIGEN; LEUKOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; THY 1 ANTIGEN;

ANTIGEN ANTIBODY REACTION; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOG; FLOW CYTOMETRY; IMMUNOCOMPETENCE; IMMUNOPHENOTYPING; LYMPHOMA; NONHUMAN; PERIPHERAL LYMPHOCYTE; REMISSION; STATISTICAL SIGNIFICANCE; T CELL LYMPHOMA; TUMOR CELL;

ANIMALS; DOG DISEASES; DOGS; IMMUNOPHENOTYPING; LYMPHOCYTES; LYMPHOMA; REFERENCE VALUES;

CANIS FAMILIARIS;

EID: 16244384168     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2005)19<193:TIOPBL>2.0.CO;2     Document Type: Article

References (33)

1. Moore AS, Leveille CR, Reimann KA, et al. The expression of P-glycoprotein in canine lymphoma and its association with multidrug resistance. Cancer Invest 1995;13:475-479.
2. Thomas R, Smith KC, Gould R, et al. Molecular cytogenetic analysis of a novel high-grade canine T-lymphoblastic lymphoma demonstrating co-expression of CD3 and CD79a cell markers. Chromosome Res 2001;9:649-657.
3. Ettinger SN. Principles of treatment for canine lymphoma. Clin Tech Small Anim Pract 2003;18:92-97.
4. Dobson JM, Blackwood LB, McInnes EF, et al. Prognostic variables in canine multicentric lymphosarcoma. J Small Anim Pract 2001;42:377-384.
5. Kiupel M, Teske E, Bostock D. Prognostic factors for treated canine malignant lymphoma. Vet Pathol 1999;36:292-300.
6. Teske E, Wisman P, Moore PF, van Heerde P. Histologic classification and immunophenotyping of canine non-Hodgkin's lymphomas: Unexpected high frequency of T cell lymphomas with B cell morphology. Exp Hematol 1994;22:1179-1187.
7. Brodersen R, Bijlsma F, Gori K, et al. Analysis of the immunological cross reactivities of 213 well characterized monoclonal antibodies with specificities against various leucocyte surface antigens of human and 11 animal species. Vet Immunol Immunopathol 1998;64:1-13.
8. Vernau W, Moore PF. An immunophenotypic study of canine leukemias and preliminary assessment of clonality by polymerase chain reaction. Vet Immunol Immunopathol 1999;69:145-164.
9. Tipold A, Moore P, Zurbriggen A, Vandevelde M. Lymphocyte subset distribution in steroid responsive meningitis-arteriitis in comparison to different canine encephalitides. Zentralbl Veterinarmed A 1999;46:75-85.
10. Chabanne L, Fournel C, Caux C, et al. Abnormalities of lymphocyte subsets in canine systemic lupus erythematosus. Autoimmunity 1995;22:1-8.
11. Hartnett BJ, Somberg RL, Krakowka S, et al. B-cell function in canine X-linked severe combined immunodeficiency. Vet Immunol Immunopathol 2000;75:121-134.
12. Raskin RE, Krehbiel JD. Prevalence of leukemic blood and bone marrow in dogs with multicentric lymphoma. J Am Vet Med Assoc. 1989;194:1427-1429.
13. Miniscalco B, Guglielmino R, Morello E, et al. Clinical usefulness of peripheral blood lymphocyte subsets in canine lymphoma. Vet Res Commun 2003;27(Suppl 1):407-409.
14. Milner RJ, Pearson J, Nesbit JW, Close P. Immunophenotypic classification of canine malignant lymphoma on formalin-fixed paraffin wax-embedded tissue by means of CD3 and CD79a cell markers. Onderstepoort J Vet Res 1996;63:309-313.
15. Garrett LD, Thamm DH, Chun R, Vail DM. Evaluation of a six month protocol with no maintenance therapy for dogs with lymphoma. 19th Annual Conference of the Veterinary Cancer Society, Woods Hole, MA, November 3-4, 1999.
16. Carter RF, Valli VE, Lumsden JH. The cytology, histology and prevalence of cell types in canine lymphoma classified according to the National Cancer Institute Working Formulation. Can J Vet Res 1986;50:154-164.
17. Dirscherl P, Beisker W, Kremmer E, et al. Immunophenotyping of canine bronchoalveolar and peripheral blood lymphocytes. Vet Immunol Immunopathol 1995;48:1-10.
18. Faldyna M, Leva L, Knotigova P, Toman M. Lymphocyte subsets in peripheral blood of dogs - A flow cytometric study. Vet Immunol Immunopathol. 2001;82:23-37.
19. Byrne KM, Kim HW, Chew BP, et al. A standardized gating technique for the generation of flow cytometry data for normal canine and normal feline blood lymphocytes. Vet Immunol Immunopathol 2000;73:167-182.
20. Hannet I, Erkeller-Yuksel F, Lydyard P, et al. Developmental and maturational changes in human blood lymphocyte subpopulations. Immunol Today 1992;13:215-218.
21. Moore PF, Rositto PW, Danilenko DM, et al. Monoclonal antibodies specific for canine CD4 and CD8 define functional T-lymphocyte subsets and high-density expression of CD4 by canine neutrophils. Tissue Antigens 1992;40:75-85.
22. Sasaki T, Sasaki-Irie J, Penninger JM. New insights into the transmembrane protein tyrosine phosphatase CD45. Int J Biochem Cell Biol 2001;33:1041-1046.
23. Hermiston ML, Xu Z, Weiss A. CD45: A critical regulator of signaling thresholds in immune cells. Annu Rev Immunol 2003;21:107-137.
24. Kalwak K, Gorczynska E, Toporski J, et al. Immune reconstitution after haematopoietic cell transplantation in children: Immunophenotype analysis with regard to factors affecting the speed of recovery. Br J Haematol 2002;118:74-89.
25. Schafer H, Bartels T, Hahn G, et al. T-cell-activating monoclonal antibodies, reacting with both leukocytes and erythrocytes, recognize the guinea pig Thy-1 differentiation antigen: Characterization and cloning of guinea pig CD90. Cell Immunol 1999;197:116-128.
26. Wucher C, Ratei R, Spahn G, et al. Impact of CD133 (AC133) and CD 90 expression analysis for acute leukemia immunophenotyping. Haematologica 2001;86:154-161.
27. Erdei A, Prechl J, Isaak A, Molnar E. Regulation of B-cell activation by complement receptors CD21 and CD35. Curr Pharm Des 2003;9:1849-1860.
28. Fischer EM, Mouhoub A, Maillet F, et al. Expression of CD21 is developmentally regulated during thymic maturation of human T lymphocytes. Int Immunol 1999;11:1841-1849.
29. Pacheco KA, Tarkowski M, Klemm J, Rosenwasser LJ. CD49d expression and function on allergen-stimulated T cells from blood and airway. Am J Respir Cell Mol Biol 1998;18:286-293.
30. De Martinis M, Modesti M, Loreto MF, et al. Adhesion molecules on peripheral blood lymphocyte subpopulations in the elderly. Life Sci 2000;68:139-151.
31. Burnett RC, Vernau W, Modiano JF, et al. Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen receptor genes. Vet Pathol 2003;40:32-41.
32. Dreitz MJ, Ogilvie G, Sim GK. Rearranged T lymphocyte antigen receptor genes as markers of malignant T cells. Vet Immunol Immunopathol 1999;69:113-119.
33. Dippel E, Assaf C, Hummel M, et al. Clonal T-cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in advanced cutaneous T-cell lymphoma: A critical evaluation. J Pathol 1999;188:146-154.